Cancer stem cells and ceramide signaling: the cutting edges of immunotherapy
- 3 September 2020
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 47 (10) , 8101-8111
Abstract
The multipotent, self renewing “cancer stem cells” (CSCs), a small population within tumor microenvironment facilitates transformed cells to grow and propagate within the body. The CSCs are discovered as resistant to the chemotherapeutic drug with distinct immunological characteristics. In recent years, immunologically targeting CSCs have emerged as an integral part of effective and successful cancer therapy. CSCs notably exhibit dysregulation in conventional sub-cellular sphingolipid metabolism. Recently, ceramide decaying enzymes have been shown to activate alternative ceramide signaling pathways leading to reduction in efficacy of the chemotherapeutic drugs. Therefore, a control over ceramide mediated modulations of CSCs offers an attractive dimension of effective cancer treatment strategy in future. In this review, we focused on the recent findings on broad spectrum of ceramide mediated signaling in CSCs within the tumor niche and their role in potential cancer immunotherapy.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (09/015(0475)2015-EMR-1)
This publication has 91 references indexed in Scilit:
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2012
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cellsProceedings of the National Academy of Sciences, 2011
- Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer CellsCancer Research, 2011
- Altered sphingolipid metabolism induced by tumor hypoxia – New vistas in glycolipid tumor markersFEBS Letters, 2009
- Heme Oxygenase-1 Contributes to an Alternative Macrophage Activation Profile Induced by Apoptotic Cell SupernatantsMolecular Biology of the Cell, 2009
- Resistance to chemotherapy: new treatments and novel insights into an old problemBritish Journal of Cancer, 2008
- A role for ceramide in driving cancer cell resistance to doxorubicinThe FASEB Journal, 2008
- Tumor Cell Apoptosis Polarizes Macrophages—Role of Sphingosine-1-PhosphateMolecular Biology of the Cell, 2007
- Leishmania donovani-Induced Ceramide as the Key Mediator of Akt Dephosphorylation in Murine Macrophages: Role of Protein Kinase Cζ and PhosphataseInfection and Immunity, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003